Pesquisar
Teva Pharmaceutical Industries Ltd
TEVAAdicionar à lista de desejos
39.810USD
-0.250-0.62%
Horário de mercado 09/22, 11:21（ET）
46.38BValor de mercado
32.33P/L TTM
Sobre o {index_name} Teva Pharmaceutical Industries Ltd Empresa
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Perfil
Código da empresaTEVA
Nome da EmpresaTeva Pharmaceutical Industries Ltd
Data de listagemFeb 06, 2087
CEOFrancis (Richard D)
Número de funcionários33892
Tipo de títulosDepository Receipt
Fim do ano fiscalFeb 06
Endereço124 Dvora Hanevi'a St.
CidadeTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIsrael
Código postal6944020
Telefone97239148213
Sitehttps://www.tevapharm.com/
Código da empresaTEVA
Data de listagemFeb 06, 2087
CEOFrancis (Richard D)
Executivos da empresa Teva Pharmaceutical Industries Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
+11.13%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
+11.35%
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
+12.10%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Perguntas frequentes
Quem são os cinco principais acionistas de Teva Pharmaceutical Industries Ltd?
Os cinco principais acionistas de Teva Pharmaceutical Industries Ltd são: Mr. Amir Elstein
Quantas instituições possuem ações da Teva Pharmaceutical Industries Ltd (TEVA)?
Em 2026Q1, 1226 instituições possuíam ações da Teva Pharmaceutical Industries Ltd, com valor de mercado aproximado de 725.07M, representando 62.27% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 9191465.00.
Qual é a maior fonte de receita da Teva Pharmaceutical Industries Ltd?
Em 2026Q1, o segmento de negócios Generic products gerou a maior receita para Teva Pharmaceutical Industries Ltd, totalizando 2.10B e representando 50.77% da receita total.